about
Genitourinary infection in diabetesNXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosisUrinary Tract Infections: Leading Initiatives in Selecting Empiric Outpatient Treatment (UTILISE).Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trialExtended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time.Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology.Antibiotic Resistance and Virulence Phenotypes of Recent Bacterial Strains Isolated from Urinary Tract Infections in Elderly Patients with Prostatic Disease.Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up studyThe role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey.Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.Renal abscess caused by a Providencia stuartii isolate biochemically misidentified as PasteurellaValue of an aggregate index in describing the impact of trends in antimicrobial resistance for Escherichia coli.Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.Antimicrobial resistance in community-acquired Escherichia coli isolated from urinary infection: Good news or bad?WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan.Management of the complications of BPH/BOO.Risk factors that influence the empirical treatment of patients with acute pyelonephritis: a cohort study.The assessment and management of urinary tract infections in adults: Guidelines for pharmacists.An unusual urinary tract infection in a healthy young man.New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study.Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis: A Multicenter, Randomized, Double-Blind, Phase 2 Study.Outcome of Patients Admitted to a Tertiary Referral Intensive Care Unit with Urosepsis Needing Source Control.Efficacy and Safety of Finafloxacin versus Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections: An Explorative Randomized Phase II Clinical Study.Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study.Antimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, PakistanPredictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infectionsImportance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches
P2860
Q24598951-CCA14A63-C70D-4160-9010-115447AFD37EQ27679097-5ACFF267-D910-487C-B24A-E3B965190468Q33553121-1703AD06-6E4F-4FD3-9EC2-B53432E23B8BQ33588033-59A86950-879A-4881-9699-94B4CE759239Q33614205-0FCF0E9E-A69B-4C90-8FA0-9ADB3034A6A4Q33617774-9BF443F0-504D-4478-A60E-253F8A302232Q33847272-15B87788-B1A2-4854-A5E1-C4DCB8FA9923Q33901475-A2352B7E-7388-4AAB-99FF-9E8B504A8E4DQ33944841-D1EA0E43-5953-4FF7-8676-8BA5F01C30A6Q34140513-29DEC213-18D0-4D2D-9E2F-88CBE7299825Q34436057-9990B122-6B8A-47A5-96BF-50008C715605Q34710133-81F7E097-2A5E-4838-9C1B-B851F4F6AEB4Q34734637-187601A3-A5CA-49DE-BB0F-650171441917Q35158122-1DB17B81-7E77-4532-9580-C1D4E8A16D4FQ35385843-1CE466EF-FED6-412F-B7EE-782E6B367786Q35928948-E291A370-31F3-446B-8ECE-3E7CDC8C0C07Q36204123-5C507EEB-8E18-47D1-8ABA-F84106AE1502Q37123720-DE4D7F03-850B-4C8F-B865-5AF75938F973Q37263472-9CFD2EE3-CB23-42C8-909F-9838CB238057Q37366741-55E7092A-DADA-4482-8715-D6A641D5F861Q37399162-5F65AF9F-9BA6-4724-98CF-F3FFF94E7CEEQ37707772-0CF8A412-0587-4A32-9ED6-ACFC3F87E021Q41991746-074BC3E2-EB3B-4B4F-B1B9-31FB5B8C01B2Q47153947-68B5D986-D039-45EC-A896-D8936405314CQ47154628-7642BB7F-EE64-4DB3-88B6-9D0A632C873CQ47231348-0B57B0B4-42C9-40A3-86AD-8DF8C31D36BDQ49598865-2CD5C0FC-610C-4C9B-BE52-F6D8987DDC3EQ49953850-EF63B555-1807-4897-ABE5-1943A84CCDADQ50020710-2520EC5E-6B85-47DD-BF89-8B88AC74C03EQ50204012-B9E5F2A1-29FE-49ED-AE4E-8AD1081FAD8EQ57945162-56B1CBB6-F49D-43EE-A1E8-95AFEEA5F1B4Q58741632-27C83E41-CAAA-43CC-8A6F-E52BAECB8EDCQ59042611-C5080297-13B7-47D6-96D1-FB69BA0E2BCA
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Complicated urinary tract infection in adults.
@ast
Complicated urinary tract infection in adults.
@en
type
label
Complicated urinary tract infection in adults.
@ast
Complicated urinary tract infection in adults.
@en
prefLabel
Complicated urinary tract infection in adults.
@ast
Complicated urinary tract infection in adults.
@en
P2860
P356
P1476
Complicated urinary tract infection in adults.
@en
P2093
AMMI Canada Guidelines Committee*
L E Nicolle
P2860
P304
P356
10.1155/2005/385768
P407
P577
2005-11-01T00:00:00Z